再发性甲状腺癌的错误诊断:测试异性恋抗体的重要性
Leila Guastapaglia1, Maria Izabel Chiamolera1,2, José Viana Lima Junior2
1Centro de Doenças da Tireoide e Laboratório de Endocrinologia Molecular e Translacional, Divisão de Endocrinologia, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Archives of endocrinology and metabolism
|March 8, 2024
概括
不同类型抗体可以导致差异化甲状腺癌患者的虚假阳性甲状腺蛋白 (Tg) 结果,导致不必要的治疗. 其他测试方法可以确认真实Tg水平,并指导适当的患者护理.
科学领域:
- 内分泌学 在内分泌学.
- 临床化学 临床化学
- 在瘤学瘤学.
背景情况:
- 甲状腺蛋白 (Tg) 是监测差异化甲状腺癌 (DTC) 复发的关键瘤标志物.
- 准确的Tg测量对于及时的临床决定至关重要,但干扰可能会损害可靠性.
相关概念视频
Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
Myasthenia Gravis: Diagnostic Tests
831
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
831


